About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Philadelphia | 632 Studies

Clinical Trials Breast CancerPhiladelphia

Breast Cancer Clinical Trials in Philadelphia

Find 632 clinical trials for breast cancer near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 401-420 of 632 trials

TerminatedStudy of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain MetastasesThe primary purpose of the study is to evaluate if motexafin gadolinium with whole brain radiation therapy followed by a stereotactic radiosurgery boost is a safe and effective…NCT00121420·Phoenix, Arizona and 11 others CompletedTai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Patients With Stage I-III Breast Cancer, the TaiChi4Joint TrialThis trial studies new methods using Tai Chi for the relief of joint pain (arthralgia) caused by an aromatase inhibitor in patients with stage I-III breast cancer.NCT04716920·Philadelphia, Pennsylvania CompletedA Study of LY3023414 in Participants With Advanced CancerThe purpose of this study is to find a recommended dose level and schedule of dosing LY3023414 that can safely be taken by participants with advanced or metastatic cancer.NCT01655225·Los Angeles, California and 7 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedPromoting Informed Choice for Breast Cancer Screening: A Longitudinal StudyAll participants will read a decision aid (DA) communicating evidence about mammography screening benefits and harms.NCT05838417·Aurora, Colorado and 1 other

CompletedCharacterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy IndexUtilizing CellSearch® technology, the ability to both enumerate and reliably and reproducibly characterize circulating tumor cells (CTC) for tumor markers that predict endocrine…NCT01701050·Phoenix, Arizona and 19 others

RecruitingShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus TrastuzumabThis phase III trial compares 6 months of human epidermal growth factor receptor 2 (HER2)-targeted therapy to 12 months of HER2-targeted therapy for the treatment of HER2-positive…NCT06876714·Phoenix, Arizona and 701 others

RecruitingThe PREDICT Registry:This is a prospective, non-interventional (observational) cohort study conducted within the medical network of the participating investigators and institutions.NCT03448926·Scottsdale, Arizona and 29 others

CompletedQuantitative Subharmonic Breast ImagingThis is a non-randomized trial of 450 women with a breast abnormality, who are scheduled for a breast biopsy of this abnormality. The study will be conducted at two clinical sites.NCT01490892·La Jolla, California and 1 other

TerminatedSafety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast CancerThis Phase I/II study is designed to assess the safety and therapeutic effect of INCB007839 in combination with trastuzumab and vinorelbine in patients with metastatic HER2+…NCT01254136·Fayetteville, Arkansas and 13 others

CompletedA Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast CancerThe purpose of this study is to evaluate the effectiveness of abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus physicians choice standard of care…NCT02675231·Bakersfield, California and 92 others

Active not recruitingHormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)This randomized phase III trial studies the best individual therapy for women who have node-negative, estrogen-receptor positive breast cancer by using a special test (Oncotype…NCT00310180·Anniston, Alabama and 1221 others

TerminatedCAR T Cells in Mesothelin-Expressing Breast CancerPhase 1 - Safety and Proof of ConceptNCT05623488·Philadelphia, Pennsylvania

CompletedA Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast CancerThis clinical trial evaluates automated breast ultrasound (ABUS) and handheld ultrasound (HHUS) for the screening of women who have undergone breast reconstruction after breast…NCT05408260·Philadelphia, Pennsylvania

RecruitingA Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast CancerThis is a Phase Ib/II, open-label, multicenter, randomized umbrella study in participants with breast cancer.NCT04802759·Duarte, California and 31 others

CompletedCombination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph NodesRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003782·Huntsville, Alabama and 156 others

CompletedT-DM1 and Palbociclib for Metastatic HER2 Breast CancerThis is a single arm, phase II study to evaluate if the combination of T-DM1 with palbociclib improves progression-free survival in patients with metastatic HER2 positive breast…NCT03530696·Tucson, Arizona and 15 others

CompletedExercise Program in Breast Cancer Patients Receiving Neoadjuvant ChemotherapyThe investigators seek to conduct a home based exercise intervention in breast cancer patients whom elect to undergo neoadjuvant chemotherapy.NCT03280836·Hershey, Pennsylvania and 1 other

CompletedSubharmonic Imaging and Pressure Estimation for Monitoring Neoadjuvant ChemotherapyThis is a diagnostic accuracy study to evaluate if two novel ultrasound (US) techniques, quantitative 3D subharmonic imaging (SHI) and Subharmonic Aided Pressure Estimation…NCT02115607·Philadelphia, Pennsylvania

CompletedRadiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in SituRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Estrogen can stimulate the growth of breast cancer cells.NCT00003857·Mobile, Alabama and 368 others

CompletedA Study of Pertuzumab With High-Dose Trastuzumab for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC) With Central Nervous System (CNS) Progression Post-RadiotherapyThis study will examine the safety and efficacy of pertuzumab in combination with high-dose trastuzumab in adult participants with HER2-positive MBC with CNS metastases and…NCT02536339·Tucson, Arizona and 15 others

PreviousPage 21 of 32Next

Other Conditions in Philadelphia

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma